- Home
- ABM vs MRUS Comparison
ABM vs MRUS Comparison
Compare ABM & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABM | MRUS |
|---|---|---|
| Founded | 1909 | 2003 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 5.1B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | ABM | MRUS |
|---|---|---|
| Price | $46.63 | $96.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 17 |
| Target Price | $55.25 | ★ $94.94 |
| AVG Volume (30 Days) | 480.3K | ★ 1.4M |
| Earning Date | 12-17-2025 | 10-31-2025 |
| Dividend Yield | ★ 2.27% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.84 | N/A |
| Revenue | ★ $8,627,900,000.00 | $56,606,000.00 |
| Revenue This Year | $5.43 | $56.08 |
| Revenue Next Year | $3.15 | N/A |
| P/E Ratio | $25.29 | ★ N/A |
| Revenue Growth | 4.27 | ★ 57.54 |
| 52 Week Low | $40.00 | $33.19 |
| 52 Week High | $57.33 | $96.94 |
Technical Indicators
Market Signals| Indicator | ABM | MRUS |
|---|---|---|
| Relative Strength Index (RSI) | 68.89 | 74.48 |
| Support Level | $44.14 | $96.60 |
| Resistance Level | $44.72 | $96.83 |
| Average True Range (ATR) | 0.77 | 0.22 |
| MACD | 0.53 | -0.15 |
| Stochastic Oscillator | 88.29 | 97.92 |
Price Performance
Historical ComparisonAbout ABM ABM Industries Incorporated
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.